Literature DB >> 17889489

Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: case report and literature review.

Chen-Hsiang Lee1, Wei-Che Lin, Ju-Hsin Chia, Lin-Hui Su, Chun-Chih Chien, Ai-Hsiu Mao, Jien-Wei Liu.   

Abstract

Chronic sclerosing osteomyelitis caused by Chryseobacterium meningosepticum was observed in a woman with steroid use. Her chronic sclerosing osteomyelitis was cured with ciprofloxacin. English literature review found 4 cases of bone-joint infection due to C. meningosepticum. The implications of treatment with a fluoroquinolone were discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889489     DOI: 10.1016/j.diagmicrobio.2007.07.009

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB.

Authors:  Lisandro J González; Alejandro J Vila
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

Review 2.  Epidemiology and Characteristics of Elizabethkingia spp. Infections in Southeast Asia.

Authors:  Asdren Zajmi; Jeanette Teo; Chew Chieng Yeo
Journal:  Microorganisms       Date:  2022-04-22

Review 3.  Septic shock caused by Elizabethkingia meningoseptica: a case report and review of literature.

Authors:  Su Hyeon Jung; Boeun Lee; Aibek E Mirrakhimov; Nasir Hussain
Journal:  BMJ Case Rep       Date:  2013-04-03

4.  Biofilm formation and adherence characteristics of an Elizabethkingia meningoseptica isolate from Oreochromis mossambicus.

Authors:  Anelet Jacobs; Hafizah Y Chenia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-05-05       Impact factor: 3.944

5.  Elizabethkingia meningoseptica: Emerging nosocomial pathogen in bedside hemodialysis patients.

Authors:  M S Ratnamani; Ratna Rao
Journal:  Indian J Crit Care Med       Date:  2013-09

6.  Waterborne Elizabethkingia meningoseptica in Adult Critical Care.

Authors:  Luke S P Moore; Daniel S Owens; Annette Jepson; Jane F Turton; Simon Ashworth; Hugo Donaldson; Alison H Holmes
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.